Correlation Between Aerovate Therapeutics and 84859DAA5

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and 84859DAA5 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and 84859DAA5 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and SR 33 01 JUN 51, you can compare the effects of market volatilities on Aerovate Therapeutics and 84859DAA5 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of 84859DAA5. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and 84859DAA5.

Diversification Opportunities for Aerovate Therapeutics and 84859DAA5

0.45

Correlation Coefficient

Aerovate Therapeutics  84859DAA5

Very weak diversification

The 3 months correlation between Aerovate and 84859DAA5 is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and SR 33 01 JUN 51 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 84859DAA5 and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with 84859DAA5. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 84859DAA5 has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and 84859DAA5 go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and 84859DAA5

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the 84859DAA5. In addition to that, Aerovate Therapeutics is 4.48 times more volatile than SR 33 01 JUN 51. It trades about 0.0 of its total potential returns per unit of risk. SR 33 01 JUN 51 is currently generating about 0.01 per unit of volatility. If you would invest  6,771  in SR 33 01 JUN 51 on October 7, 2024 and sell it today you would earn a total of  5.00  from holding SR 33 01 JUN 51 or generate 0.07% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	31.85%
Values	Daily Returns

Aerovate Therapeutics  vs.  SR 33 01 JUN 51

Aerovate Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

84859DAA5

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SR 33 01 JUN 51 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for SR 33 01 JUN 51 investors.

Pair Trading with Aerovate Therapeutics and 84859DAA5

The main advantage of trading using opposite Aerovate Therapeutics and 84859DAA5 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, 84859DAA5 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 84859DAA5 will offset losses from the drop in 84859DAA5's long position.

The idea behind Aerovate Therapeutics and SR 33 01 JUN 51 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.